BCL2 and lymphoma: This approach enabled the clustering of lymphomas with co-occurring MYD88- and CD79B mutations (MCD), BCL6 rearrangements and NOTCH2 mutations (BN2), EZH2 mutations and BCL2 rearrangements (EZB), as well as NOTCH1 mutations (N1) (2).